Cohance Lifesciences Limited (NSE:COHANCE)
425.25
-0.05 (-0.01%)
Jul 31, 2026, 3:30 PM IST
Cohance Lifesciences Employees
Cohance Lifesciences had 1,212 employees as of March 31, 2025. The number of employees increased by 19 or 1.59% compared to the previous year.
Employees
1,212
Change
19
Growth
1.59%
Revenue / Employee
18.72M INR
Profits / Employee
1.48M INR
Market Cap
162.61B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 1,212 | 19 | 1.59% |
| Mar 31, 2022 | 1,193 | 79 | 7.09% |
| Mar 31, 2021 | 1,114 | 142 | 14.61% |
| Mar 31, 2020 | 972 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Alembic Pharmaceuticals | 17,244 |
| Akums Drugs and Pharmaceuticals | 7,337 |
| Piramal Pharma | 7,120 |
| Emcure Pharmaceuticals | 6,731 |
| NATCO Pharma | 4,199 |
| Strides Pharma Science | 3,535 |
| Eris Lifesciences | 3,354 |
| Wockhardt | 2,564 |
Cohance Lifesciences News
- 2 months ago - Cohance Lifesciences Transcript: Q4 25/26 - Transcripts
- 2 months ago - Cohance Lifesciences Quarterly report: Q4 2026 - Filings
- 2 months ago - Cohance Lifesciences Slides: Q4 2026 - Filings
- 6 months ago - Cohance Lifesciences Transcript: Q3 25/26 - Transcripts
- 6 months ago - Cohance Lifesciences Quarterly report: Q3 2026 - Filings
- 6 months ago - Cohance Lifesciences Slides: Q3 2026 - Filings
- 9 months ago - Cohance Lifesciences Transcript: Q2 25/26 - Transcripts
- 9 months ago - Cohance Lifesciences Quarterly report: Q2 2026 - Filings